<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="of Cambridge, [3], [4], [5], 0000 0001 2353 6535grid.428999.7Environment and" exact="Infectious" post="Risks Unit, Institut Pasteur, epub: 2020-6-6pmc-release: 2020-6-6collection: 2020112842received: 2019-9-19accepted:"/>
 <result pre="but challenging due to cross-reactivity with other alphaviruses such as" exact="chikungunya" post="virus (CHIKV). Here, we develop an analytical framework to"/>
 <result pre="evidence of an important sylvatic cycle for MAYV with most" exact="infections" post="occurring near the natural reservoir in rural areas and"/>
 <result pre="in individuals more likely to go to the forest (i.e.," exact="adult" post="males) and with seroprevalences of up to 18% in"/>
 <result pre="in some areas of French Guiana. Subject terms Statistical methods" exact="Viral infection" post="Epidemiology Funding This study was supported by the &quot;European"/>
 <result pre="some areas of French Guiana. Subject terms Statistical methods Viral" exact="infection" post="Epidemiology Funding This study was supported by the &quot;European"/>
 <result pre="Investissement d’Avenir program, the Laboratoire d’Excellence Integrative Biology of Emerging" exact="Infectious" post="Diseases program (Grant ANR-10-LABX-62-IBEID), the Models of Infectious Disease"/>
 <result pre="d’Avenir program, the Laboratoire d’Excellence Integrative Biology of Emerging Infectious" exact="Diseases" post="program (Grant ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent"/>
 <result pre="of Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID), the Models of" exact="Infectious" post="Disease Agent Study of the National Institute of General"/>
 <result pre="Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID), the Models of Infectious" exact="Disease" post="Agent Study of the National Institute of General Medical"/>
 <result pre="of Infectious Disease Agent Study of the National Institute of" exact="General" post="Medical Sciences, the INCEPTION project (PIA/ANR-16-CONV-0005), the European Union’s"/>
 <result pre="various areas including urban settings in Caribbean area, South and" exact="Central" post="America7–10, but surprisingly little is known about its circulation"/>
 <result pre="CHIKV in the Americas since 2013, the evaluation of MAYV" exact="infection" post="is greatly complicated by serological cross-reactivity where CHIKV infected"/>
 <result pre="also exhibit a signal for CHIKV (Fig. 1a). In the" exact="absence of" post="a good understanding of the antibody response following exposure"/>
 <result pre="1b). For example, while the average MAYV RFI is much" exact="lower" post="than the average CHIKV RFI in Cayenne, it is"/>
 <result pre="infection. Our approach jointly estimates the location-specific annual force of" exact="infection" post="(FOI, per capita rate at which a susceptible individual"/>
 <result pre="RFIs change to both the infecting and non-infecting virus following" exact="infection" post="(see Methods). In a simulation study, we find that"/>
 <result pre="approach is able to reliably estimate model parameters and reconstruct" exact="viral" post="circulation histories (See Supplementary Tables 2 and 3). Fig."/>
 <result pre="with MAYV and by 0.22 (95% CrI: 0.20–0.23) after a" exact="CHIKV infection" post="while CHIKV RFI increases by 1.05 (95% CrI: 1.01–1.1)"/>
 <result pre="MAYV and by 0.22 (95% CrI: 0.20–0.23) after a CHIKV" exact="infection" post="while CHIKV RFI increases by 1.05 (95% CrI: 1.01–1.1)"/>
 <result pre="RFI increases by 1.05 (95% CrI: 1.01–1.1) after a MAYV" exact="infection" post="and by 3.64 (95% CrI: 3.60–3.67) after a CHIKV"/>
 <result pre="MAYV infection and by 3.64 (95% CrI: 3.60–3.67) after a" exact="CHIKV infection" post="(Tab S4). Assessing the history of virus circulation In"/>
 <result pre="infection and by 3.64 (95% CrI: 3.60–3.67) after a CHIKV" exact="infection" post="(Tab S4). Assessing the history of virus circulation In"/>
 <result pre="to cross-reactivity, our model assesses the history of circulation and" exact="infection" post="risk factors for each virus. For MAYV, our best"/>
 <result pre="Supplementary Tables 6 and 7) assumes that the force of" exact="infection" post="for MAYV has remained stable over time, with important"/>
 <result pre="assumes that the force of infection for MAYV has remained" exact="stable" post="over time, with important regional variations (Fig. 2a). At"/>
 <result pre="than children (Fig. 2b). Living in a carbet (typical Native" exact="American" post="cabin without walls) is a risk factor for MAYV"/>
 <result pre="American cabin without walls) is a risk factor for MAYV" exact="infection" post="(OR: 1.4, 95% CrI: 0.8–2.3). These estimates support the"/>
 <result pre="scenario of a sylvatic transmission cycle for MAYV where most" exact="infections" post="occur near the natural reservoir in rural areas and"/>
 <result pre="where individuals more likely to go to the forest (i.e.," exact="adult" post="males) are also at higher risk of infection. Fig."/>
 <result pre="infection. a Best model fit of the yearly probability of" exact="infection" post="by MAYV (purple) and CHIKV (orange) of an adult"/>
 <result pre="of infection by MAYV (purple) and CHIKV (orange) of an" exact="adult" post="male in the different regions of French Guiana. Solid"/>
 <result pre="of French Guiana. Solid lines indicate the mean probability of" exact="infection" post="and envelopes the 95% credible intervals. b Relative risk"/>
 <result pre="intervals. b Relative risk of MAYV (purple) and CHIKV (orange)" exact="infection" post="of individuals above 20 years old (relative to younger"/>
 <result pre="other types of habitations. Data are presented as the mean" exact="posterior" post="with error bars denoting 95% credible intervals and the"/>
 <result pre="be infected (Fig. 2b). We find an increased risk of" exact="CHIKV infection" post="for individuals that spend more time at home. We"/>
 <result pre="infected (Fig. 2b). We find an increased risk of CHIKV" exact="infection" post="for individuals that spend more time at home. We"/>
 <result pre="whether this observation could help explain the increased level of" exact="CHIKV infection" post="among women. In the survey, participants were asked the"/>
 <result pre="this observation could help explain the increased level of CHIKV" exact="infection" post="among women. In the survey, participants were asked the"/>
 <result pre="at home. Spending time at home was also associated with" exact="infection" post="by CHIKV (OR, 95% CrI: 1.84 (1.41–2.40)), but not"/>
 <result pre="95% CrI: 1.84 (1.41–2.40)), but not significantly associated with MAYV" exact="infection" post="(OR, 95% CrI: 1.30 (0.79–2.14)). These findings are consistent"/>
 <result pre="explained by differential boosting of the RFI rather than different" exact="viral" post="exposure levels. We ran the same model using only"/>
 <result pre="the data (Supplementary Figs. 1 and 2). Model-based classification of" exact="infection" post="Once parameters characterizing cross-reactivity and the force of infection"/>
 <result pre="of infection Once parameters characterizing cross-reactivity and the force of" exact="infection" post="have been estimated, the model can be used to"/>
 <result pre="for each possible value of the assays the probability of" exact="infection" post="by MAYV and/or CHIKV and classifies the result as"/>
 <result pre="classifies the result as infected if the estimated probability of" exact="infection" post="is above 50% (Fig. 3a). To validate the model-based"/>
 <result pre="a Graphical representation of the model-based classification that determines the" exact="infection" post="status for MAYV and CHIKV from the measured MAYV"/>
 <result pre="curve. The boundaries were plotted considering a probability of MAYV" exact="infection" post="of 5% and CHIKV infection of 20% (see Supplementary"/>
 <result pre="plotted considering a probability of MAYV infection of 5% and" exact="CHIKV infection" post="of 20% (see Supplementary Fig. 4 for a sensitivity"/>
 <result pre="considering a probability of MAYV infection of 5% and CHIKV" exact="infection" post="of 20% (see Supplementary Fig. 4 for a sensitivity"/>
 <result pre="(see Supplementary Fig. 4 for a sensitivity analysis where the" exact="infection" post="probabilities are changed). b Contingency tables comparing the simple"/>
 <result pre="the seroneutralization assay (performed on 100 individuals) as a reference." exact="Geographic" post="distribution of seroprevalence From the analysis of transmission dynamics"/>
 <result pre="found high MAYV seroprevalence in this region17. A majority of" exact="infections" post="inferred by the model (68%) came from the Maroni"/>
 <result pre="49,169 inhabitants have been infected, and the annual probability of" exact="infection" post="is 0.45% (95% CrI: 0.35–0.56) – or 223 (95%"/>
 <result pre="(95% CrI: 0.35–0.56) – or 223 (95% CrI: 175–271) new" exact="infections" post="per year (Supplementary Table 11). These results show that"/>
 <result pre="sylvatic transmission of MAYV. We also found individuals with historical" exact="infections" post="of MAYV in the urban regions characterized by low"/>
 <result pre="serological data, it is not possible to determine whether these" exact="infections" post="occurred in these regions or during travel to other"/>
 <result pre="these regions or during travel to other areas. Fig. 4" exact="Geographic" post="distribution of MAYV and CHIKV seroprevalence. a Three regions"/>
 <result pre="confidence intervals of the weighted seroprevalence, respectively. Had we inferred" exact="infections" post="with a simple optimized cut-off, cross-reactivity with CHIKV would"/>
 <result pre="would have led to overestimating the number of historical MAYV" exact="infections" post="by almost 100% (estimated number of infections: 13,838 compared"/>
 <result pre="MAYV, our best fitting model had a constant risk of" exact="infection" post="over time, with the individual risk of infection increasing"/>
 <result pre="risk of infection over time, with the individual risk of" exact="infection" post="increasing with age. As cross-sectional serological surveys do not"/>
 <result pre="this result could be equally explained by larger rates of" exact="infection" post="in the past and no difference in exposure between"/>
 <result pre="the forest-dwelling mosquito Haemagogus, which is consistent with exposures in" exact="adult" post="men who work in the forest. To assess the"/>
 <result pre="is important to understand how the CHIKV outbreak affected the" exact="susceptibility to" post="MAYV. With our model-based classification, we found only five"/>
 <result pre="classification, we found only five individuals with evidence of historical" exact="infections" post="by both viruses. While this may be indicative of"/>
 <result pre="a cluster effect. To reach the desired sample size, a" exact="total" post="of 1600 households were randomly selected for possible participation"/>
 <result pre="participation in the study from household databases maintained by the" exact="Geographic" post="information and knowledge dissemination unit of the Regional environment,"/>
 <result pre="one of the 22 strata (municipalities); – Mi: number of" exact="primary" post="sampling units (households) in the ith stratum, i = 1, …,"/>
 <result pre="the ith stratum, i = 1, …, 22; – Si: number of" exact="primary" post="sampling units (households) selected from the ith stratum, i = 1,"/>
 <result pre="the ith stratum, i = 1, …, 22; – mi: number of" exact="primary" post="sampling units (households) actually enrolled in the study from"/>
 <result pre="each municipality to match the distribution in the French Guiana" exact="total" post="population. Ten age groups ([2–5 years] [5–10], [10–15], [15–20],"/>
 <result pre="[45–55], [55–65], and ≥65 years) were defined within male and" exact="female" post="groups, and for each age-sex subgroup, we applied an"/>
 <result pre="responsible for ethical issues and protection of individual data collection." exact="Blood" post="sample collection Blood samples were collected into 5 mL gold"/>
 <result pre="issues and protection of individual data collection. Blood sample collection" exact="Blood" post="samples were collected into 5 mL gold BD Vacutainer SST"/>
 <result pre="microsphere sets (Luminex Corp., Austin, TX) were, respectively, bound to" exact="viral" post="and control proteins using the amine coupling kit (Bio-Rad"/>
 <result pre="at 1:10 mixed in equal volume with 100 tissue culture" exact="infectious" post="dose 50 (TCID 50) of MAYV or CHIKV (French"/>
 <result pre="as the reciprocal of the highest serum dilution at which" exact="infection" post="is blocked. A serum is considered positive for titer"/>
 <result pre="for this study. Notation We consider an individual j. The" exact="infection" post="status Ij indicates whether individual j was infected by"/>
 <result pre="infected by MAYV and/or CHIKV. The ensemble of all possible" exact="infection" post="statuses is I = {(1,0), (0,1), (0,0), (1,1)} where the first"/>
 <result pre="of the model We start with the scenario where the" exact="infection" post="status is known and then move on to when"/>
 <result pre="We can break down the probability of measured RFIs and" exact="infection" post="status into two components: 1 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts}"/>
 <result pre="dynamics model and the second part the virus circulation model." exact="Antibody" post="dynamics model We model the serological response of an"/>
 <result pre="the serological response of an individual as the result of" exact="infections" post="by MAYV and/or CHIKV. Several mechanisms contribute to the"/>
 <result pre="MAYV and/or CHIKV. Several mechanisms contribute to the assay outcome:" exact="infection" post="leads to a boost of the RFI for the"/>
 <result pre="We derive the four probabilities of measured RFIs given the" exact="infection" post="status: 1. If an individual has not been infected,"/>
 <result pre="\usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t_j^{\mathrm{M}}$$\end{document} t j M after" exact="infection" post="3 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek}"/>
 <result pre="proportional to the infecting virus response, and a model where" exact="infection" post="by both viruses leads to an increase in RFI"/>
 <result pre="age-specific seroprevalence profiles is key to estimate historical patterns of" exact="viral" post="circulation and the associated risk factors of exposure. Methods"/>
 <result pre="models are commonly used to reconstruct the annual force of" exact="infection" post="(per capita rate at which susceptible individuals are infected"/>
 <result pre="λi the FOI on year i, the probability to survive" exact="infection" post="during year i for an individual susceptible to infection"/>
 <result pre="survive infection during year i for an individual susceptible to" exact="infection" post="at the start of year i is equal to"/>
 <result pre="= 1 − exp − a j λ . 2." exact="Epidemic" post="model We consider for the epidemic model a single"/>
 <result pre="year at which the FOI is maximal, α is the" exact="total" post="FOI. Predictors of infection in the serocatalytic models In"/>
 <result pre="FOI is maximal, α is the total FOI. Predictors of" exact="infection" post="in the serocatalytic models In addition to temporal variations"/>
 <result pre="in a particular region as predictors of the risk of" exact="infection" post="by MAYV and CHIKV. We included these predictors in"/>
 <result pre="j , housing j , income j ) . The" exact="total" post="cumulative strengths of MAYV and CHIKV infection for individual"/>
 <result pre="j ) . The total cumulative strengths of MAYV and" exact="CHIKV infection" post="for individual j are 9 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts}"/>
 <result pre=") . The total cumulative strengths of MAYV and CHIKV" exact="infection" post="for individual j are 9 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts}"/>
 <result pre="M ( age j − i ) is the relative" exact="susceptibility to" post="MAYV infections of individuals at age agej−i compared with"/>
 <result pre="j − i ) is the relative susceptibility to MAYV" exact="infections" post="of individuals at age agej−i compared with adults (children"/>
 <result pre="risks of infection, we extend Eq. (6) and obtain the" exact="infection" post="probabilities: 11 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs}"/>
 <result pre="identify the spatial spread of CHIKV. Inference: In practice the" exact="infection" post="status is unknown and only the RFIs are observed."/>
 <result pre="of individual j has to be summed over all possible" exact="infection" post="statuses and is 12 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb}"/>
 <result pre="priors where chosen for most of the antibody model and" exact="viral" post="circulation parameters. The prior distributions are Uniform (0,5) for"/>
 <result pre="were defined as the 2.5% and 97.5% percentiles of the" exact="posterior" post="distributions. Parameter estimates for the model for antibody dynamics"/>
 <result pre="a univariate logistic regression model to predict MAYV and/or CHIKV" exact="infections" post="determined by the model with socio-demographic or environmental variables."/>
 <result pre="in the FOI model. Model-based classification of MAYV and CHIKV" exact="infections" post="Conditional on parameter value θ, the probability that individual"/>
 <result pre="parameter value θ, the probability that individual j has an" exact="infection" post="profile Ij is given by 13 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym}"/>
 <result pre="I k ∣ �?�� , X j ) where the" exact="infection" post="probabilities are given in Eq. (11) and the denominator"/>
 <result pre="(11) and the denominator is a sum over the four" exact="infection" post="profiles. The expected infection status for individual j is"/>
 <result pre="is a sum over the four infection profiles. The expected" exact="infection" post="status for individual j is obtained by averaging the"/>
 <result pre="is obtained by averaging the probability (Eq. 13) over the" exact="posterior" post="distribution of parameters \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy}"/>
 <result pre="θs the parameter vector with index s in the chain." exact="Infection" post="status of an individual is assessed by taking the"/>
 <result pre="an individual is assessed by taking the most likely expected" exact="infection" post="status. We plotted in Fig. 3a the areas of"/>
 <result pre="infection status. We plotted in Fig. 3a the areas of" exact="infection" post="profiles fixing infection probabilities \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb}"/>
 <result pre="plotted in Fig. 3a the areas of infection profiles fixing" exact="infection" post="probabilities \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek}"/>
 <result pre="importance of PM and PC in the determination of the" exact="infection" post="profile, we plotted the boundaries for various values of"/>
 <result pre="profile, we plotted the boundaries for various values of the" exact="infection" post="probability (Supplementary Fig. 3). We show that values of"/>
 <result pre="of PM and PC have little impact on the likely" exact="infection" post="profile which is therefore mostly determined by the RFI"/>
 <result pre="by the RFI values. The number of infected individuals The" exact="total" post="number of infections was obtained from the individual model-based"/>
 <result pre="values. The number of infected individuals The total number of" exact="infections" post="was obtained from the individual model-based predictions of infections"/>
 <result pre="of infections was obtained from the individual model-based predictions of" exact="infections" post="weighted by the sampling weights. The 95% confidence intervals"/>
 <result pre="sampling weights. The 95% confidence intervals of the number of" exact="infections" post="were estimated from 10,000 bootstrap resamples where each individual"/>
 <result pre="and where each individual weight was renormalized to keep the" exact="total" post="weight unchanged (representing the total number of inhabitants in"/>
 <result pre="was renormalized to keep the total weight unchanged (representing the" exact="total" post="number of inhabitants in French Guiana or within a"/>
 <result pre="within a subregion of interest). The annual probability of MAYV" exact="infection" post="was estimated with the formula \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts}"/>
 <result pre="}\nolimits_j w_j}}$$\end{document} ∑ j w j P j M annual" exact="infection" post="∑ j w j where \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts}"/>
 <result pre="{{\mathrm{annual}}\;{\mathrm{infection}}} \right) = P_j^{{\mathrm{M}}_{{\mathrm{never}}\;{\mathrm{infected}}}} \times P_j^{{\mathrm{M}}_{{\mathrm{infected}}\;{\mathrm{this}}\;{\mathrm{year}}}}$$\end{document} P j M annual" exact="infection" post="= P j M never infected × P j"/>
 <result pre="\right) \times \lambda _{2017}^{\mathrm{M}}} \right)} \right)$$\end{document} P j M annual" exact="infection" post="= e − Λ j M 1 − exp"/>
 <result pre="X j , − 1 × λ 2017 M Annual" exact="infection" post="probabilities for MAYV are reported in Supplementary Table 11."/>
 <result pre="and sex were no longer significant risk factors for MAYV" exact="infection" post="(OR: 1.2, 95% CrI: 0.9–1.6). The reason for these"/>
 <result pre="as in the dataset and with parameters drawn from the" exact="posterior" post="distribution. The simulated surveys could reproduce the observed age"/>
 <result pre="our approach to identify the correct epidemiological (constant force of" exact="infection" post="vs. epidemic transmission), we simulated serological surveys for each"/>
 <result pre="the first simulation, we assumed a constant annual probability of" exact="infection" post="of 0.01. In the second, we assumed an outbreak"/>
 <result pre="42 for the epidemic model survey. We also estimated the" exact="posterior" post="distribution of the parameters. The probability of infection in"/>
 <result pre="estimated the posterior distribution of the parameters. The probability of" exact="infection" post="in the first model is 0.94% (95% CrI: 0.78–1.11%)"/>
 <result pre="to be 1979 (95% CrI: 1977–1981) and the probability of" exact="infection" post="is 22% (95% CrI: 16–28%). Evaluation of the statistical"/>
 <result pre="framework. One survey was simulated with parameters equal to the" exact="posterior" post="mean we estimated in our analysis. We ran our"/>
 <result pre="antibody model dynamics (Supplementary Table 2) and model-based classification of" exact="infections" post="for the number of infected by MAYV and/or CHIKV"/>
 <result pre="study, by • Considering other models of antibody response after" exact="infection" post="• Assuming different models of virus circulation • Removing"/>
 <result pre=", ε C In a third model, we considered that" exact="infection" post="by both viruses leads to a boosting of the"/>
 <result pre="cross- reactivity (DIC = 10,343, vs. 11,832, 10,531, and 10,364 for the" exact="absence of" post="cross-reactivity, the other cross-reactivity model, and the increased boosting"/>
 <result pre="observed (Supplementary Table 6). Alternative models for risk factors of" exact="infection" post="We fitted the data by removing one predictor of"/>
 <result pre="males compared to females (parameters εM and εC). The mean" exact="posterior" post="of εM was 0.51 (95% CrI: 0.50–0.53) for females"/>
 <result pre="females and 0.54 (95% CrI: 0.52–0.56) for males. The mean" exact="posterior" post="of εC was 0.39 (95% CrI: 0.38–0.41) for females"/>
 <result pre="baseline where we did not account for differential boosting. The" exact="total" post="number of infected individuals was 73 males and 58"/>
 <result pre="Investissement d’Avenir program, the Laboratoire d’Excellence Integrative Biology of Emerging" exact="Infectious" post="Diseases program (Grant ANR-10-LABX-62-IBEID), the Models of Infectious Disease"/>
 <result pre="d’Avenir program, the Laboratoire d’Excellence Integrative Biology of Emerging Infectious" exact="Diseases" post="program (Grant ANR-10-LABX-62-IBEID), the Models of Infectious Disease Agent"/>
 <result pre="of Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID), the Models of" exact="Infectious" post="Disease Agent Study of the National Institute of General"/>
 <result pre="Emerging Infectious Diseases program (Grant ANR-10-LABX-62-IBEID), the Models of Infectious" exact="Disease" post="Agent Study of the National Institute of General Medical"/>
 <result pre="of Infectious Disease Agent Study of the National Institute of" exact="General" post="Medical Sciences, the INCEPTION project (PIA/ANR-16-CONV-0005), the European Union’s"/>
 <result pre="investigations. C.Fl., S.C., and H.S. designed the EPIARBO study. C.Fl." exact="acquired" post="funding. Data availability The following data is available in"/>
 <result pre="the Amazon basinSci. Rep20177871810.1038/s41598-017-07152-528821712 4.LednickyJet al.Mayaro virus in child with" exact="acute" post="Febrile Illness, Haiti, 2015Emerg. Infect. Dis.2016222000200210.3201/eid2211.16101527767924 5.Paniz-MondolfiAERodriguez-MoralesAJBlohmGMarquezMVillamil-GomezWEChikDenMaZika syndrome: the"/>
 <result pre="2015Emerg. Infect. Dis.2016222000200210.3201/eid2211.16101527767924 5.Paniz-MondolfiAERodriguez-MoralesAJBlohmGMarquezMVillamil-GomezWEChikDenMaZika syndrome: the challenge of diagnosing arboviral" exact="infections" post="in the midst of concurrent epidemicsAnn. Clin. Microbiol. Antimicrob.2016154210.1186/s12941-016-0157-x27449770"/>
 <result pre="deforestation, and prediction of zoonoses emergenceEmerg. Infect. Dis.2005111822182710.3201/eid1112.04078916485465 7.HalseyESet al.Mayaro" exact="virus infection," post="Amazon Basin region, Peru, 2010-2013Emerg. Infect. Dis.2013191839184210.3201/eid1911.13077724210165 8.Acosta-AmpudiaYet al.Mayaro:"/>
 <result pre="Basin region, Peru, 2010-2013Emerg. Infect. Dis.2013191839184210.3201/eid1911.13077724210165 8.Acosta-AmpudiaYet al.Mayaro: an emerging" exact="viral" post="threat?Emerg. Microbes Infect.2018716310.1038/s41426-018-0163-530254258 9.BruniniSet al.High frequency of Mayaro virus"/>
 <result pre="9.BruniniSet al.High frequency of Mayaro virus IgM among febrile patients," exact="Central" post="BrazilEmerg. Infect. Dis.2017231025102610.3201/eid2306.16092928518022 10.PAHO/WHO. 1 May 2019: Mayaro fever-epidemiological"/>
 <result pre="(2019). 11.SaljeHet al.Nationally-representative serostudy of dengue in Bangladesh allows generalizable" exact="disease" post="burden estimatesElife20198e4286910.7554/eLife.4286930958263 12.PezziLet al.GloPID-R report on Chikungunya, O’nyong-nyong and"/>
 <result pre="sanitaire en région Antilles-Guyane. Point Epidémiologique de janvier 2015: Le" exact="chikungunya" post="dans les Antilles 1–6, (in French, 2015). 14.Cellule de"/>
 <result pre="sanitaire en région Antilles-Guyane. Point Epidémiologique de juillet 2014: Le" exact="chikungunya" post="dans les Antilles 1–7, (in French, 2014). 15.FritzellCet al.Knowledge,"/>
 <result pre="(in French, 2014). 15.FritzellCet al.Knowledge, attitude and practices of vector-borne" exact="disease" post="prevention during the emergence of a new arbovirus: implications"/>
 <result pre="French GuianaPLoS Negl. Trop. Dis.201610e000508110.1371/journal.pntd.000508127802275 16.Llagonne-BaretsMet al.A case of Mayaro" exact="virus infection" post="imported from French GuianaJ. Clin. Virol.201677666810.1016/j.jcv.2016.02.01326921736 17.TalarminAet al.Mayaro virus"/>
 <result pre="GuianaPLoS Negl. Trop. Dis.201610e000508110.1371/journal.pntd.000508127802275 16.Llagonne-BaretsMet al.A case of Mayaro virus" exact="infection" post="imported from French GuianaJ. Clin. Virol.201677666810.1016/j.jcv.2016.02.01326921736 17.TalarminAet al.Mayaro virus"/>
 <result pre="al.How social structures, space, and behaviors shape the spread of" exact="infectious diseases" post="using chikungunya as a case studyProc. Natl Acad. Sci"/>
 <result pre="space, and behaviors shape the spread of infectious diseases using" exact="chikungunya" post="as a case studyProc. Natl Acad. Sci USA2016113134201342510.1073/pnas.161139111327821727 22.EpelboinYet"/>
 <result pre="Inst. Oswaldo Cruz2018113e17039810.1590/0074-0276017039829538490 23.FritzellCet al.Current challenges and implications for dengue," exact="chikungunya" post="and Zika seroprevalence studies worldwide: a scoping reviewPLoS Negl."/>
 <result pre="studies worldwide: a scoping reviewPLoS Negl. Trop. Dis.201812e000653310.1371/journal.pntd.000653330011271 24.Cao-LormeauVMet al.Guillain-Barre" exact="Syndrome" post="outbreak associated with Zika virus infection in French Polynesia:"/>
 <result pre="Negl. Trop. Dis.201812e000653310.1371/journal.pntd.000653330011271 24.Cao-LormeauVMet al.Guillain-Barre Syndrome outbreak associated with Zika" exact="virus infection" post="in French Polynesia: a case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 25.CauchemezSet al.Household transmission"/>
 <result pre="Trop. Dis.201812e000653310.1371/journal.pntd.000653330011271 24.Cao-LormeauVMet al.Guillain-Barre Syndrome outbreak associated with Zika virus" exact="infection" post="in French Polynesia: a case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 25.CauchemezSet al.Household transmission"/>
</results>
